Truist Securities analyst Danielle Brill assumes coverage on WAVE Life Sciences (NASDAQ: WVE) with a Buy rating and a price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage